Related references
Note: Only part of the references are listed.Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen
H. M. Crauwels et al.
HIV MEDICINE (2019)
Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint
Sarita D. Boyd et al.
AIDS (2019)
Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV
Jeremiah D. Momper et al.
AIDS (2018)
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Alice Stek et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Pharmacokinetics of drugs in pregnancy
Maisa Feghali et al.
SEMINARS IN PERINATOLOGY (2015)
Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial
Karen Tashima et al.
AIDS RESEARCH AND THERAPY (2014)
Physiologic and pharmacokinetic changes in pregnancy
Maged M. Costantine
FRONTIERS IN PHARMACOLOGY (2014)
Induction of Hepatic CYP3A Enzymes by Pregnancy-Related Hormones: Studies in Human Hepatocytes and Hepatic Cell Lines
Ioannis Papageorgiou et al.
DRUG METABOLISM AND DISPOSITION (2013)
The higher barrier of darunavir and tipranavir resistance for HIV-1 protease
Yong Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients
Adrian Curran et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Darunavir Inhibitory Quotient Predicts the 48-Week Virological Response to Darunavir-Based Salvage Therapy in Human Immunodeficiency Virus-Infected Protease Inhibitor-Experienced Patients
Jose Molto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy
TS Tracy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Safety and pharmacokinetics of antiretroviral therapy during pregnancy
NY Rakhmanina et al.
THERAPEUTIC DRUG MONITORING (2004)
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women
EP Acosta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacokinetics of antiretrovirals in pregnant women
M Mirochnick et al.
CLINICAL PHARMACOKINETICS (2004)
Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle
MA Sarkar et al.
DRUG METABOLISM AND DISPOSITION (2003)
Share Paper
